主动脉内球囊阻断复苏在穿透性胸部创伤大出血中可行:一种新的机构内部署算法
本研究为在哥伦比亚一家一级创伤中心开展的前瞻性观察性研究,纳入2015年1月至2019年12月所有接受REBOA的14岁以上严重创伤患者,纳入条件为失血性休克且对复苏无反应。共56例患者置入REBOA,其中37例为穿透性创伤、23例为胸部创伤;所有患者到达急诊时血流动力学不稳定,中位收缩压69 mmHg(IQR 57-90 mmHg),中位损伤严重度评分25(IQR 25-41)。所有REBOA均于1区部署并充盈,中位充盈时间40分钟(IQR 26-55分钟),未观察到不良神经结局。总体死亡率为28.6%,穿透性创伤与钝性创伤患者死亡率无显著差异(21.6% vs 42.1%,p=0.11);胸部创伤患者生存率与预测生存率相似(65.2% vs 63.3%)。作者结论认为REBOA可安全用于穿透性胸部创伤,且由训练有素的多学科团队实施REBOA管理算法是可行的。
要点
- 对失血性休克且对复苏无反应的严重创伤患者(含穿透性胸部创伤)可置入REBOA;本研究中所有REBOA均于1区部署并充盈。
- 本研究中REBOA中位充盈时间为40分钟(IQR 26-55分钟),未观察到不良神经结局。
- 本组总体死亡率为28.6%,穿透性创伤与钝性创伤患者死亡率无显著差异(21.6% vs 42.1%,p=0.11)。
- 胸部创伤患者生存率与预测生存率相似(65.2% vs 63.3%)。
- 作者认为REBOA可安全用于穿透性胸部创伤,由训练有素的多学科团队实施REBOA管理算法是可行的。
适用人群与场景
- 纳入标准:年龄大于14岁、严重创伤、于2015年1月至2019年12月期间接受REBOA的患者;患者因失血性休克且对复苏无反应而接受REBOA。
- 研究场景:哥伦比亚一家一级创伤中心。
诊断标准与关键阈值
- 接受REBOA的条件:处于失血性休克且对复苏无反应。
处置流程与药物剂量
- REBOA置入后于1区部署并充盈;本研究中所有REBOA均于1区部署并充盈,中位充盈时间40分钟(IQR 26-55分钟)。
- 15例患者接受REBOA并正中胸骨切开术;11例患者合并腹部伤口。
研究设计与关键结果
- 研究类型:前瞻性观察性研究,在哥伦比亚一家一级创伤中心开展;共56例患者接受REBOA置入,其中37例为穿透性创伤、23例为胸部创伤。
- 所有患者到达急诊时血流动力学不稳定,中位收缩压69 mmHg(IQR 57-90 mmHg),中位损伤严重度评分25(IQR 25-41)。
- 所有REBOA均于1区部署并充盈,中位充盈时间40分钟(IQR 26-55分钟),未观察到不良神经结局。
- 总体死亡率为28.6%;穿透性创伤与钝性创伤患者死亡率无显著差异(21.6% vs 42.1%,p=0.11)。
- 胸部创伤患者生存率与预测生存率相似(65.2% vs 63.3%)。
证据类型、等级与局限
- 证据类型:前瞻性观察性研究;证据等级:治疗性,V级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为REBOA可安全用于穿透性胸部创伤,由训练有素的多学科团队实施REBOA管理算法是可行的。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is an emerging option for hemorrhage control, but its use is limited in scenarios such as penetrating chest trauma. The aim of this study was to describe the use of REBOA as a resuscitative adjunct in these cases with major hemorrhage and to propose a new clinical management algorithm.
METHODS: This was a prospective, observational study conducted at a single Level I trauma center in Colombia. We included all patients older than 14 years with severe trauma who underwent REBOA from January 2015 to December 2019. Patients received REBOA if they were in hemorrhagic shock and were unresponsive to resuscitation.
RESULTS: A total of 56 patients underwent REBOA placement of which 37 had penetrating trauma and 23 had chest trauma. All patients were hemodynamically unstable upon arrival to the emergency department, with a median systolic blood pressure of 69 mm Hg (interquartile range [IQR], 57-90 mm Hg) and median Injury Severity Score was 25 (IQR, 25-41). All REBOAs were deployed and inflated in zone 1, median inflation time was 40 minutes (IQR, 26-55 minutes), and no adverse neurologic outcomes were observed. Fifteen patients had REBOA and a median sternotomy. Eleven patients had concomitant abdominal wounds. Overall mortality was 28.6%, and there was no significant difference between penetrating versus blunt trauma patients (21.6% vs. 42.1%, p = 0.11). The survival rate of thoracic injured patients was similar to the predicted survival (65.2% vs. 63.3%).
CONCLUSION: Resuscitative endovascular balloon occlusion of the aorta can be used safely in penetrating chest trauma, and the implementation of a REBOA management algorithm is feasible with a well-trained multidisciplinary team.
LEVEL OF EVIDENCE: Therapeutic, level V.
参考来源
- Ordoñez CA, Rodríguez F, Parra M, et al. Resuscitative endovascular balloon of the aorta is feasible in penetrating chest trauma with major hemorrhage: Proposal of a new institutional deployment algorithm. J Trauma Acute Care Surg. 2020. PMID: 32345890. doi:10.1097/TA.0000000000002773
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。